Table:
begin	end	state
1	25	cytoplasmic
26	44	transmembrane
45	64	non-cytoplasmic
65	83	transmembrane
84	93	cytoplasmic
94	115	transmembrane
116	120	non-cytoplasmic
121	140	transmembrane
141	159	cytoplasmic
160	182	transmembrane
183	187	non-cytoplasmic
188	207	transmembrane
208	253	cytoplasmic
254	272	transmembrane
273	292	non-cytoplasmic
293	311	transmembrane
312	322	cytoplasmic
323	341	transmembrane
342	352	non-cytoplasmic
353	373	transmembrane
374	382	cytoplasmic
383	404	transmembrane
405	415	non-cytoplasmic
416	436	transmembrane
437	447	cytoplasmic

Input:
>WP_046156002.1 NCBI__GCF_000971335.1:WP_046156002.1
MISLFKPAPHLPPLPDAQQHGLYRRLRWQIFLGIFLGYAGYYLVRKNFSLAMPYLVEQGF
SRGDLGFAMSGVAIAYGLSKFLMGAVSDRSNPRVFLSAGLVLSAAVFLLMGFAPWATSSV
GVMFVLLFLNGWFQGMGWPACGRTMVHWWSQKERGGVVSIWNCAHNVGGGLIGPLFILGM
GWFNDWRAAFYVPAAAAIGVAVFAWLTMRDTPQSCGLPPVEAYRNDYPEDYSDTHEQELT
AREIFRKYILPNKLLWYIALANVFIYLLRYGVLDWAPTYLKEVKHFSVDKSSWAYFLYEW
AGIPGTLLCGWMSDKLFRGNRGATGVFFMALVTLATVVYWLNPAGNPTVDMLALIAIGFL
IYGPVMLVGLHALELAPKKAAGTAAGFTGLFGYLGGSVAANAAVGYTVDHFGWDGGFALL
IGSCVAAIVLLALTTWHGHQQGKLASA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server